Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Gastrointestinal Cancer
New Clues to Mismatch Repair and PD-1/PD-L1 Status and Survival in Patients with Gastric or Esophageal Cancer
By
Charles Bankhead
Gastrointestinal Cancer
,
Web Exclusives
Read More ›
Human Epidermal Growth Factor Receptor Type 2 Therapy in Gastrointestinal Tumors
Federico Longo, MD; Alfredo Carrato, MD, PhD
Medical Oncology Department, Ramon y Cajal University Hospital
Madrid, Spain
Gastrointestinal Cancer
Read More ›
Adding Radiation to First-Line FOLFOX Reduces Progression of Liver Metastases in Patients with Metastatic Colorectal Cancer
Gastrointestinal Cancer
Read More ›
Bevacizumab Wins Cost-Effectiveness Analysis in First-Line Metastatic Colorectal Cancer
Gastrointestinal Cancer
Read More ›
Immunotherapy Holds Promise to Extend Survival in GI Cancers
By
Wayne Kuznar
Gastrointestinal Cancer
Read More ›